{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:08:07Z","timestamp":1776377287983,"version":"3.51.2"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.149008","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:06:11Z","timestamp":1763111171000},"page":"149008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Design, development, and in vivo characterization of ocular pH-based in situ thixotropic gelling system for the therapy of Glaucoma"],"prefix":"10.1016","volume":"334","author":[{"given":"Aanchal","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagyashri","family":"Atre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendra","family":"Nagaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundeep","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.149008_bb0005","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0010","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OPX.0000000000000863","article-title":"Value of routine eye examinations in asymptomatic patients","volume":"93","author":"Irving","year":"2016","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10384-018-0566-9","article-title":"Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma","volume":"62","author":"Honjo","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0025","first-page":"1029","article-title":"Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632","volume":"42","author":"Vasantha Rao","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0035","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1167\/iovs.05-1617","article-title":"Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys","volume":"48","author":"Tokushige","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/IJG.0b013e3182952213","article-title":"Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes","volume":"24","author":"Wang","year":"2015","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0045","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2147\/OPTH.S216907","article-title":"Ripasudil hydrochloride hydrate in the treatment of glaucoma: Safety, efficacy, and patient selection","volume":"14","author":"Kusuhara","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/jop.2016.0028","article-title":"Ocular penetration and pharmacokinetics of ripasudil following topical administration to rabbits","volume":"32","author":"Isobe","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0055","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1080\/14656566.2017.1378344","article-title":"Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma","volume":"18","author":"Inoue","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0060","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.drudis.2019.04.002","article-title":"Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development","volume":"24","author":"Gukasyan","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0065","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149008_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-023-01123-9","article-title":"Revolutionizing ocular drug delivery: recent advancements in in situ gel technology","volume":"47","author":"Paul","year":"2023","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0075","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.xphs.2018.01.019","article-title":"D-optimal design in the development of rheologically improved in situ forming ophthalmic gel","volume":"107","author":"Krtali\u0107","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.eurpolymj.2012.12.009","article-title":"Chitosan-based biomaterials for tissue engineering","volume":"49","author":"Croisier","year":"2013","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0085","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/pi.5331","article-title":"Chitosan-based hydrogels: recent design concepts to tailor properties and functions","volume":"66","author":"Racine","year":"2017","journal-title":"Polym. Int."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0090","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/pr9101694","article-title":"Development and optimization of chitosan-hydroxypropyl methylcellulose in situ gelling systems for ophthalmic delivery of bupivacaine hydrochloride","volume":"9","author":"Popa","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0095","unstructured":"benecelTM e4m hydroxypropyl methylcellulose, (n.d.). https:\/\/www.ashland.com\/industries\/personal-and-home-care\/oral-care\/benecele4mhpmc (accessed July 24, 2025)."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10812-023-01523-9","article-title":"Development and validation of UV-spectrophotometric method towards determination of ripasudil hydrochloride hydrate in pure and ophthalmic formulation","volume":"90","author":"Arora","year":"2023","journal-title":"J. Appl. Spectrosc."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2185180","article-title":"Design and evaluation of in situ gel eye drops containing nanoparticles of Gemifloxacin Mesylate","volume":"30","author":"Kalaria","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3797\/scipharm.1010-04","article-title":"Study of thermo-sensitive in-situ gels for ocular delivery","volume":"79","author":"Bhowmik","year":"2011","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0115","series-title":"Response Surface Methodology in Engineering Science","article-title":"Central composite design for response surface methodology and its application in pharmacy","author":"Bhattacharya","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0120","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s13346-022-01260-0","article-title":"Central composite design\u2013based optimization, fabrication, and pharmacodynamic assessment of sulfasalazine-loaded lipoidal nanoparticle-based hydrogel for the management of rheumatoid arthritis","volume":"13","author":"Mishra","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248857","article-title":"Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections","volume":"16","author":"Nair","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0130","first-page":"1","article-title":"Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride","volume":"6","author":"Makwana","year":"2016","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4274\/tjps.2016.05","article-title":"Development and characterization of Voriconazole loaded in situ gel formulations for ophthalmic application","volume":"13","author":"\u00dcstundag Okur","year":"2016","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0140","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2147\/IJN.S131850","article-title":"A potential in situ gel formulation loaded with novel fabricated poly(Lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole","volume":"12","author":"Ahmed","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0145","first-page":"35","article-title":"Formulation and evaluation of an in situ gel for ocular drug delivery of anticonjunctival drug","volume":"49","author":"Patil","year":"2015","journal-title":"Cellul. Chem. Technol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0150","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.xphs.2019.04.005","article-title":"An ex vivo evaluation of moxifloxacin nanostructured lipid carrier enriched in situ gel for transcorneal permeation on goat cornea","volume":"108","author":"Gade","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0155","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s13346-022-01155-0","article-title":"Gellan gum\u2013based in situ gelling ophthalmic nanosuspension of Posaconazole","volume":"12","author":"Khare","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120380","article-title":"Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma","volume":"598","author":"Allam","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2016.12.038","article-title":"An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration","volume":"247","author":"Zhao","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0170","article-title":"Intraocular pressure in genetically distinct mice: an update and strain survey","volume":"2","author":"Savinova","year":"2001","journal-title":"BMC Genet."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0175","article-title":"Oral scutellarin treatment ameliorates retinal thinning and visual deficits in experimental glaucoma","volume":"8","author":"Zhu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0180","series-title":"Steroid-Induced Glaucoma, Childhood Glaucoma: A Case Based Color and Video Atlas","first-page":"235","author":"Varshney","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0185","first-page":"170","article-title":"Acute effects of dexamethasone on intraocular pressure in glaucoma - PubMed","volume":"26","author":"Weinreb","year":"1985","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0190","article-title":"Production and physicochemical characterization of chitosan for the harvesting of wild microalgae consortia","volume":"28","author":"Acosta-Ferreira","year":"2020","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0195","article-title":"Considerations for polymers used in ocular drug delivery","volume":"8","author":"Allyn","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0200","article-title":"Ripasudil as a potential therapeutic agent in treating secondary glaucoma in HTLV-1-uveitis: an in vitro analysis","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0205","article-title":"Advances and challenges in the use of chitosan and its derivatives in biomedical fields: a review","volume":"5","author":"Yadav","year":"2023","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0210","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.3390\/polym13193256","article-title":"Chitosan: an overview of its properties and applications","volume":"13","author":"Aranaz","year":"2021","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0215","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/molecules28041963","article-title":"Chitosan-based nanoparticles as effective drug delivery systems\u2014a review","volume":"28","author":"Jafernik","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/md16100373","article-title":"Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review","volume":"16","author":"Irimia","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0225","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/fsn3.1206","article-title":"Effect of various additives on the properties of the films and coatings derived from hydroxypropyl methylcellulose\u2014a review","volume":"7","author":"Ghadermazi","year":"2019","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijbiomac.2022.06.094","article-title":"Fabrication of moldable chitosan gels via thermally induced phase separation in aqueous alcohol solutions","volume":"215","author":"Sochilina","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23201","article-title":"Wetting and swelling behaviour of N-acetylated thin chitosan coatings in aqueous media","volume":"10","author":"M\u00e1rton","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0240","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0245","first-page":"922","article-title":"Preparation and characterization of bear bile-loaded pH sensitive in-situ gel eye drops for ocular drug delivery","volume":"23","author":"Ni","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2009.02.013","article-title":"Thixotropic property in pharmaceutical formulations","volume":"136","author":"Lee","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2022.2158964","article-title":"Poloxamer sols endowed with in-situ gelability and mucoadhesion by adding hypromellose and hyaluronan for prolonging corneal retention and drug delivery","volume":"30","author":"Chen","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2011.04.052","article-title":"Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system","volume":"414","author":"Liu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131587","article-title":"Influence of chitosan protonation degree in nanofibrillated cellulose\/chitosan composite films and their morphological, mechanical, and surface properties","volume":"267","author":"Torres","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121218","article-title":"Role of physicochemical properties of some grades of hydroxypropyl methylcellulose on in vitro mucoadhesion","volume":"609","author":"Zhang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0275","series-title":"Progress in Polymer Science (Oxford)","first-page":"603","article-title":"Chitin and chitosan: properties and applications","volume":"31","author":"Rinaudo","year":"2006"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0280","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.3390\/molecules25173981","article-title":"Chitosan: a natural biopolymer with a wide and varied range of applications","volume":"25","author":"Jim\u00e9nez-G\u00f3mez","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/polym12071519","article-title":"Chitosan and its derivatives for ocular delivery formulations: recent advances and developments","volume":"12","author":"Zamboulis","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121218","article-title":"Role of physicochemical properties of some grades of hydroxypropyl methylcellulose on in vitro mucoadhesion","volume":"609","author":"Zhang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37430","article-title":"A central composite design-based targeted quercetin nanoliposomal formulation: optimization and cytotoxic studies on MCF-7 breast cancer cell lines","volume":"10","author":"Bhargav","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-024-00611-7","article-title":"Evaluating the prediction power and accuracy of two smart response surface experimental designs after revisiting repaglinide floating tablets","volume":"10","author":"Elsayed","year":"2024","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0305","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1038\/s41598-020-66357-3","article-title":"Central composite design for optimizing the biosynthesis of silver nanoparticles using plantago major extract and investigating antibacterial, antifungal and antioxidant activity","volume":"10","author":"Nikaeen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0310","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.carbpol.2016.02.080","article-title":"Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment","volume":"144","author":"Cheng","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0315","article-title":"Chitosan\/\u03b2-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of mitomycin-C","volume":"1","author":"Kolawole","year":"2019","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0320","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.3390\/ijms22179652","article-title":"Advances in chitosan-based nanoparticles for drug delivery","volume":"22","author":"Miku\u0161ov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","article-title":"An overview of chitosan nanoparticles and its application in non-parenteral drug delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0330","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/bm101192b","article-title":"In situ gelable interpenetrating double network hydrogel formulated from binary components: thiolated chitosan and oxidized dextran","volume":"12","author":"Zhang","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119213","article-title":"In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in animal model","volume":"580","author":"Abdel-Salam","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0340","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/ma4101861","article-title":"Sol-gel behavior of hydroxypropyl methylcellulose (HPMC) in ionic media including drug release","volume":"4","author":"Joshi","year":"2011","journal-title":"Materials"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0350","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/pharmaceutics17060784","article-title":"Hydroxypropyl methylcellulose\u2014a key excipient in pharmaceutical drug delivery systems","volume":"17","author":"Vlad","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0355","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.carbpol.2013.11.017","article-title":"Thermal gelation of aqueous hydroxypropylmethylcellulose solutions with SDS and hydrophobic drug particles","volume":"102","author":"Acevedo","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118734","article-title":"Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time","volume":"574","author":"Destruel","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0975-7406.149810","article-title":"An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention","volume":"7","author":"Gupta","year":"2015","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2018.02.022","article-title":"In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery","volume":"88","author":"Song","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0375","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3797\/scipharm.1001-06","article-title":"Carbopol\/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate","volume":"78","author":"Gupta","year":"2010","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0380","unstructured":"Steady state flux: Significance and symbolism, (n.d.). https:\/\/www.wisdomlib.org\/concept\/steady-state-flux (accessed July 24, 2025)."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0385","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.65.11.28","article-title":"Mathematical models of ocular drug delivery","volume":"65","author":"Sadeghi","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/gels8110687","article-title":"Development of ciprofloxacin-loaded bilosomes in-situ gel for ocular delivery: optimization, in-vitro characterization, ex-vivo permeation, and antimicrobial study","volume":"8","author":"Alsaidan","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0395","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","article-title":"Eta squared and partial eta squared as measures of effect size in educational research","volume":"6","author":"Richardson","year":"2011","journal-title":"Educ. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0400","unstructured":"What is Partial Eta Squared? (Definition & Example), (n.d.). https:\/\/www.statology.org\/partial-eta-squared\/ (accessed July 24, 2025)."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0410","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3109\/03639045.2015.1137306","article-title":"Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept","volume":"42","author":"Patel","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0415","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1248\/yakushi.127.183","article-title":"Preparation and evaluation of a Carbopol\/HPMC-based in situ gelling ophthalmic system for puerarin","volume":"127","author":"Wu","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s13346-015-0262-y","article-title":"Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery","volume":"6","author":"Ambhore","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149008_bb0425","doi-asserted-by":"crossref","DOI":"10.5812\/jjnpp.13938","article-title":"A novel microemulsion system for ocular delivery of Azithromycin: design, characterization and ex-vivo rabbit corneal permeability","volume":"12","author":"Salimi","year":"2017","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0430","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/10717544.2021.2023236","article-title":"Hybrid thermosensitive-mucoadhesive in situ forming gels for enhanced corneal wound healing effect of L-carnosine","volume":"29","author":"Fathalla","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0435","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s13346-021-01072-8","article-title":"Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study","volume":"12","author":"Kaul","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0440","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/03639045.2016.1185437","article-title":"Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole","volume":"42","author":"Kumar","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0445","doi-asserted-by":"crossref","DOI":"10.3109\/10717544.2014.987333","article-title":"Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel","volume":"23","author":"Kesarla","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0450","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/DDDT.S293127","article-title":"Development and characterization of PLGA nanoparticle-laden hydrogels for sustained ocular delivery of norfloxacin in the treatment of pseudomonas keratitis: an experimental study","volume":"15","author":"Gebreel","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0455","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1316249","article-title":"Investigations on polymeric nanoparticles for ocular delivery","volume":"2019","author":"Mittal","year":"2019","journal-title":"Adv. Polym. Technol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110503","article-title":"Chitosan-based hydrogels: revolutionizing corneal wound healing with antibacterial and regenerative properties","volume":"258","author":"Hussain","year":"2025","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2017.11.170","article-title":"Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: in-vitro characterization, ocular tolerance and antibacterial activity","volume":"108","author":"Ameeduzzafar","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0470","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/ph14111201","article-title":"Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems","volume":"14","author":"Gupta","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0475","article-title":"Development of mucoadhesive methacrylic anhydride-modified hydroxypropyl methylcellulose hydrogels for topical ocular drug delivery","volume":"93","author":"Cheng","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0480","doi-asserted-by":"crossref","unstructured":"P. Agarwal, T. Raghu, R. Singh, H.B. Mohamed, M. Ali, A. Shafie, A.I. Mekkawy, Chitosan nanoparticles for Meloxicam ocular delivery: development, in vitro characterization, and in vivo evaluation in a rabbit eye model, Pharmaceutics 2022, Vol. 14, Page 893 14 (2022) 893. doi:https:\/\/doi.org\/10.3390\/PHARMACEUTICS14050893.","DOI":"10.3390\/pharmaceutics14050893"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0485","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/pharmaceutics14050893","article-title":"Chitosan nanoparticles for Meloxicam ocular delivery: development, in vitro characterization, and in vivo evaluation in a rabbit eye model","volume":"14","author":"Mohamed","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0490","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijbiomac.2014.02.002","article-title":"Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits","volume":"65","author":"Ameeduzzafar","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105359","article-title":"Silver and gold nanoparticles exposure to in Vitro cultured retina - Studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity","volume":"9","author":"S\u00f6derstjerna","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08820538.2015.1114865","article-title":"Drug delivery nanoparticles: toxicity comparison in retinal pigment epithelium and retinal vascular endothelial cells","volume":"31","author":"Lin","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0505","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5487\/TR.2019.35.3.287","article-title":"In vitro cytotoxicity of zinc oxide nanoparticles in cultured statens Seruminstitut Rabbit Cornea Cells","volume":"35","author":"Lee","year":"2019","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0510","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.biocel.2013.06.002","article-title":"Zinc oxide nanoparticles decrease the expression and activity of plasma membrane calcium ATPase, disrupt the ntracellular calcium homeostasis in rat retinal ganglion cells","volume":"45","author":"Guo","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0515","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/jfb3030615","article-title":"Biocompatibility of chitosan carriers with application in drug delivery","volume":"3","author":"Rodrigues","year":"2012","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0520","doi-asserted-by":"crossref","first-page":"654","DOI":"10.5530\/ijper.53.4.127","article-title":"Formulation and characterization of pH induced in situ gels containing sulfacetamide sodium for ocular drug delivery: a combination of Carbopol\u00ae\/HPMC polymer","volume":"53","author":"Sheshala","year":"2019","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: a smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0530","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/antiox12050993","article-title":"In-situ thermoresponsive hydrogel containing resveratrol-loaded nanoparticles as a localized drug delivery platform for dry eye disease","volume":"12","author":"De Luca","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/polym15214336","article-title":"Ophthalmic bimatoprost-loaded niosomal in situ gel: preparation, optimization, and in vivo pharmacodynamics study","volume":"15","author":"Aldawsari","year":"2023","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/polym12071519","article-title":"Chitosan and its derivatives for ocular delivery formulations: recent advances and developments","volume":"12","author":"Zamboulis","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0545","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/jfb3030615","article-title":"Biocompatibility of chitosan carriers with application in drug delivery","volume":"3","author":"Rodrigues","year":"2012","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0550","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2024.05.031","article-title":"In situ gelling systems for ocular drug delivery","volume":"371","author":"Ahmed","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0555","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2023.01.007","article-title":"In situ gelling drug delivery systems for topical drug delivery","volume":"184","author":"Kolawole","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119020","article-title":"New nanoparticles for topical ocular delivery of erythropoietin","volume":"576","author":"Silva","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0565","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1039\/D2BM01413K","article-title":"Injectable composite hydrogels encapsulating gelatin methacryloyl\/chitosan microspheres as ARPE-19 cell transplantation carriers","volume":"11","author":"Cheng","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118688","article-title":"Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability","volume":"570","author":"Shi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701808","article-title":"Memantine-loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma","volume":"14","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0580","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10717544.2022.2058648","article-title":"Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment","volume":"29","author":"Radwan","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0585","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.4103\/IJO.IJO_2706_22","article-title":"Prostaglandin analogs in ophthalmology","volume":"71","author":"Subbulakshmi","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0590","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jcm12010044","article-title":"Effect of topical prostaglandin analogue therapy on central corneal thickness: a systematic review","volume":"12","author":"Kim","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0595","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/OED.S4909","article-title":"Clinical options for the reduction of elevated intraocular pressure","volume":"4","author":"Crawley","year":"2012","journal-title":"Ophthalmol. Eye Dis."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0600","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2217\/17410541.5.4.377","article-title":"Pharmacogenetics of ophthalmic topical \u03b2-blockers","volume":"5","author":"Sidjanin","year":"2008","journal-title":"Per. Med."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0605","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: relative value and place in therapy of available drug treatments","volume":"5","author":"Sambhara","year":"2014","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0610","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ophtha.2008.09.054","article-title":"Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy","volume":"116","author":"Liu","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0615","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2016.04.019","article-title":"Efficacy of latanoprostene bunod 0.024% compared with timolol 0.5% in lowering intraocular pressure over 24 hours","volume":"169","author":"Liu","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0620","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","article-title":"Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure","volume":"138","author":"Liu","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0625","first-page":"741","article-title":"Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension","volume":"4","author":"Lee","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0630","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/0301-4738.40362","article-title":"Practical approach to medical management of glaucoma","volume":"56","author":"Parikh","year":"2008","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0635","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/aos.13790","article-title":"Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study","volume":"96","author":"Lind\u00e9n","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0640","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","article-title":"Primary open-angle glaucoma preferred practice pattern\u00ae","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0645","unstructured":"A Guide to Applying IOP-lowering Drugs, (n.d.). https:\/\/www.reviewofoptometry.com\/article\/a-guide-to-applying-ioplowering-drugs (accessed August 29, 2025)."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0650","doi-asserted-by":"crossref","DOI":"10.4137\/OED.S4909","article-title":"Clinical options for the reduction of elevated intraocular pressure","volume":"4","author":"Crawley","year":"2012","journal-title":"Ophthalmol. Eye Dis."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112008","article-title":"Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment","volume":"142","author":"El-Feky","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0660","doi-asserted-by":"crossref","DOI":"10.3109\/03639045.2013.814061","article-title":"Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study","volume":"40","author":"Singh","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0665","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1167\/iovs.13-13025","article-title":"The influence of genetic background on conventional outflow facility in mice","volume":"54","author":"Boussommier-Calleja","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0670","article-title":"Intraocular pressure in genetically distinct mice: an update and strain survey","volume":"2","author":"Savinova","year":"2001","journal-title":"BMC Genet."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0675","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1167\/iovs.05-0781","article-title":"Noninvasive measurement of rodent intraocular pressure with a rebound tonometer","volume":"46","author":"Wang","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149008_bb0680","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajpath.2016.12.003","article-title":"Dexamethasone-induced ocular hypertension in mice: effects of myocilin and route of administration","volume":"187","author":"Patel","year":"2017","journal-title":"Am. J. Pathol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025095650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025095650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:43:24Z","timestamp":1764711804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025095650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":136,"alternative-id":["S0141813025095650"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149008","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, development, and in vivo characterization of ocular pH-based in situ thixotropic gelling system for the therapy of Glaucoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149008"}}